Showing results (341-350 of 348) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 348 results.
Infection|September 30, 2022
A case of fulminant respiratory diphtheria in a 24-year-old Afghan refugee in Austria in May 2022: a case reportM T Traugott, S Pleininger, S Inschlag-Tisch, et al.
Frontiers in Cardiovascular Medicine|March 20, 2024
Severe COVID-19 and its cardiopulmonary effects 6 and 18 months after hospital dischargeJ H Niebauer, A Iscel, S Schedl, et al.
Infection|June 15, 2020
Successful management of the first reported case in Austria of COVID-19 with ARDST Seitz, W Hoepler, L Weseslindtner, et al.
Frontiers in Pharmacology|August 8, 2022
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)M Karolyi, E Pawelka, S Omid, et al.
Infection|April 13, 2016
Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious DiseasesK de With, F Allerberger, S Amann, et al.
Lupus|March 13, 2001
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluationA J Swaak, H G van den Brink, R J Smeenk, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Rheumatology (Oxford, England)|February 7, 2001
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)A J Swaak, H van de Brink, R J Smeenk, et al.
Pageof 35